HISTOPATHOLOGY LIMITED - Accounts

HISTOPATHOLOGY LIMITED - Accounts

HISTOPATHOLOGY LIMITED - Company Information

Print Friendly Version

2022-08-01 2023-07-31 false Capium Accounts Production 1.1 07308886 bus:AbridgedAccounts 2022-08-01 2023-07-31 07308886 bus:FRS102 2022-08-01 2023-07-31 07308886 bus:AuditExemptWithAccountantsReport 2022-08-01 2023-07-31 07308886 bus:SmallCompaniesRegimeForAccounts 2022-08-01 2023-07-31 07308886 bus:PrivateLimitedCompanyLtd 2022-08-01 2023-07-31 07308886 2022-08-01 2023-07-31 07308886 2023-07-31 07308886 bus:RegisteredOffice 2022-08-01 2023-07-31 07308886 core:WithinOneYear 2023-07-31 07308886 core:AfterOneYear 2023-07-31 07308886 bus:Director1 2022-08-01 2023-07-31 07308886 bus:Director1 2023-07-31 07308886 bus:Director1 2021-08-01 2022-07-31 07308886 2021-08-01 07308886 bus:CompanySecretary1 2022-08-01 2023-07-31 07308886 bus:LeadAgentIfApplicable 2022-08-01 2023-07-31 07308886 2021-08-01 2022-07-31 07308886 2022-07-31 07308886 core:WithinOneYear 2022-07-31 07308886 core:AfterOneYear 2022-07-31 07308886 bus:EntityAccountantsOrAuditors 2021-08-01 2022-07-31 07308886 core:ComputerEquipment 2022-08-01 2023-07-31 07308886 core:ComputerEquipment 2023-07-31 07308886 core:ComputerEquipment 2022-07-31 07308886 core:LeasedAssetsHeldAsLessee core:PlantMachinery 2023-07-31 07308886 core:LeasedAssetsHeldAsLessee core:PlantMachinery 2022-07-31 07308886 core:CostValuation core:Non-currentFinancialInstruments 2023-07-31 07308886 core:CostValuation core:Non-currentFinancialInstruments 2022-07-31 07308886 core:AdditionsToInvestments core:Non-currentFinancialInstruments 2023-07-31 07308886 core:DisposalsDecreaseInInvestments core:Non-currentFinancialInstruments 2023-07-31 07308886 core:RevaluationsIncreaseDecreaseInInvestments core:Non-currentFinancialInstruments 2023-07-31 07308886 core:Non-currentFinancialInstruments 2023-07-31 07308886 core:Non-currentFinancialInstruments 2022-07-31 07308886 core:ShareCapital 2023-07-31 07308886 core:ShareCapital 2022-07-31 07308886 core:RetainedEarningsAccumulatedLosses 2023-07-31 07308886 core:RetainedEarningsAccumulatedLosses 2022-07-31 07308886 dpl:Item1 2022-08-01 07308886 dpl:Item1 2023-07-31 07308886 dpl:Item1 2021-08-01 07308886 dpl:Item1 2022-07-31 iso4217:GBP xbrli:shares xbrli:pure
Registered Number: 07308886
England and Wales

 

 

 

HISTOPATHOLOGY LIMITED


Abridged Accounts
 


Period of accounts

Start date: 01 August 2022

End date: 31 July 2023
 
 		 Notes
 		 2023
£		   2022
£
Fixed assets      
Tangible fixed assets 3 0    776 
0    776 
Current assets      
Cash at bank and in hand 84,213    54,558 
Creditors: amount falling due within one year (6,968)   (3,211)
Net current assets 77,245    51,347 
 
Total assets less current liabilities 77,245    52,123 
Net assets 77,245    52,123 
 

Capital and reserves 		     
Called up share capital 2    2 
Profit and loss account 77,243    52,121 
Shareholder's funds 77,245    52,123 
 


For the year ended 31 July 2023 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's responsibilities:
  1. The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476.
  2. The director acknowledges their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.
These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime and in accordance with the provisions of Part 15 of the Companies Act 2006. In accordance with Section 444 of the Companies Act 2006, the income statement has not been delivered to the Registrar of Companies.

The members have agreed to the preparation of abridged accounts for this accounting period in accordance with section 444(2A).
The financial statements were approved by the director on 06 December 2023 and were signed by:


-------------------------------
Petya Nedeva
Director
1
General Information
HISTOPATHOLOGY LIMITED is a private company, limited by shares, registered in England and Wales, registration number 07308886, registration address Beulau Hill, Idole, CARMARTHEN, SA32 8DH.

The presentation currency is £ sterling.
1.

Accounting policies

Significant accounting policies
Statement of compliance
These financial statements have been prepared in compliance with FRS 102 – The Financial Reporting Standard applicable in the UK and Republic of Ireland and the Companies Act 2006.
Basis of preparation
The financial statements have been prepared under the historical cost convention as modified by the revaluation of land and buildings and certain financial instruments measured at fair value in accordance with the accounting policies.
The financial statements are prepared in sterling which is the functional currency of the company.
Turnover
Turnover comprises the invoiced value of goods and services supplied by the company, net of Value Added Tax and trade discounts.
Taxation
Taxation represents the sum of tax currently payable and deferred tax. Tax is recognised in the statement of income, except to the extent that it relates to items recognised in other comprehensive income or directly in capital and reserves.
The company’s liability for current tax is calculated using the tax rates and laws that have been enacted or substantively enacted at the reporting date.
Current and deferred tax assets and liabilities are not discounted
Deferred taxation
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the reporting date.
Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the reporting date that are expected to apply to the reversal of the timing difference.
Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.
Current and deferred tax assets and liabilities are not discounted.
Tangible fixed assets
Tangible fixed assets, other than freehold land, are stated at cost or valuation less depreciation and any provision for impairment. Depreciation is provided at rates calculated to write off the cost or valuation of fixed assets, less their estimated residual value, over their expected useful lives on the following basis:
Equipment 18% Reducing Balance
2.

Average number of employees

Average number of employees during the year was 0 (2022 : 0).
3.

Tangible fixed assets

Cost or valuation Equipment   Total
  £   £
At 01 August 2022 4,325    4,325 
Additions -    - 
Disposals -    - 
At 31 July 2023 4,325    4,325 
Depreciation
At 01 August 2022 3,548    3,548 
Charge for year 777    777 
On disposals -    - 
At 31 July 2023 4,325    4,325 
Net book values
Closing balance as at 31 July 2023 -    - 
Opening balance as at 01 August 2022 776    776 


2